Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2003
10/15/2003EP1351934A1 Naphthalene derivatives which bind to the ep4 receptor
10/15/2003EP1351933A1 Il-8 receptor antagonists
10/15/2003EP1351929A1 Nitric oxide synthase inhibitor phosphate salt
10/15/2003EP1351924A2 Diamines as modulators of chemokine receptor activity
10/15/2003EP1351707A2 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
10/15/2003EP1351704A2 Storage stable powder compositions of interleukin-4 receptor
10/15/2003EP1351703A2 Use of a polypeptide comprising the extracellular domains of il-20ra and il-20rb for the treatment of inflammation
10/15/2003EP1351702A1 Trem-1 splice variant for use in modifying immune responses
10/15/2003EP1351681A2 Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts
10/15/2003EP1351678A2 Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens
10/15/2003EP1351672A1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders
10/15/2003EP1351671A1 Triphenylmethane kinesin inhibitors
10/15/2003EP1268471B1 N-heterocyclic derivatives as nos inhibitors
10/15/2003EP1259508B1 Novel biarylcarboxamides
10/15/2003EP1246799B1 Substituted pyrrole mannich bases to combat pain and allergic reactions
10/15/2003EP1183037B1 Compositions for modulating immune response and for the treatment of inflammatory disease
10/15/2003EP0888351B1 Pyrimido 5,4-d]pyrimidines, medicaments containing these compounds, their use and process for their production
10/15/2003EP0876140B1 Improved kontrast agent solutions for intravenous administration
10/15/2003EP0796276B1 Gradual modification, super-agonists and antagonists of signal-proteins and peptides
10/15/2003CN1449390A Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
10/15/2003CN1449385A Aza-bridged-bicyclic amino acid derivatives as alpha4 integrin antagonists
10/15/2003CN1449377A Inhibitors of alpha4 mediated cell adhesion
10/15/2003CN1449294A Parenteral vaccine formulations and uses thereof
10/15/2003CN1449293A Multivalent vaccine composition
10/15/2003CN1449285A Use of il-8 receptor antagonists in the treatment of virus infections
10/15/2003CN1448406A Human B lymphocyte stimulating factor mutant and constructing method and coding gene thereof
10/15/2003CN1448173A Cymose buckwheat rhizome preparation,production method and use thereof
10/15/2003CN1124276C Rapamycin derivatives
10/15/2003CN1124157C Pharmaceutical compositions
10/15/2003CN1124145C Chinese patent medicine for treating allergic dermatopathy
10/15/2003CN1124138C Male silkmoth capsule and its preparing process
10/15/2003CN1124135C Use of rapamycin derivatives in vasculopathies and xenotransplantation
10/14/2003US6632962 Caspase inhibitors and uses thereof
10/14/2003US6632945 Treating inflammation, autoimmune diseases, destructive bone disorders, proliferative disorders, infections, neurvous system disorders, reperfusion/ischemia in stroke, cardiovascular disorders, hypoxia, edema, fever, pain
10/14/2003US6632928 Immunotoxins and methods of inducing immune tolerance
10/14/2003US6632920 Immunology; diagnosing cancer, nervous system, brain, sleep, psychological, and disorders
10/14/2003US6632836 To treat autoimmune disorders, cardiac arrhythmias and the like
10/14/2003US6632830 ACE-2 inhibiting compounds and methods of use thereof
10/14/2003US6632810 Cyclic diamine compound with condensed-ring groups
10/14/2003US6632789 Contacting with inhibitor or activator of phosphatidylinositol 3-kinase
10/14/2003US6632647 Use of strains of parapoxvirus ovis against organ fibrosis
10/14/2003US6632608 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or T cell subset activity by modulation of XBP-1 activity
10/14/2003US6632459 For prophylaxis and therapy of diseases, infections
10/14/2003CA2385777A1 Use of anti-tnf.alpha.antibodies and another drug
10/14/2003CA2085827C Adjuvant composition containing synthetic hydrophobic lipopolysaccharide
10/14/2003CA2080018C Novel t-cell lymphoma cdna clones
10/14/2003CA2040001C Hypoallergenic wheat preparation, process for producing the same, and processed food including the same
10/09/2003WO2003083442A2 Life sciences business systems and methods
10/09/2003WO2003083139A1 Method of examining allergic disease
10/09/2003WO2003083124A2 Peptide epitopes common to antigens of the same multigene family
10/09/2003WO2003083098A2 Nucleic acid sequence and protein in addition to polypeptides coding for mannitol-dehydrogenases or parts thereof and the production and use thereof in diagnosis and therapy
10/09/2003WO2003083089A2 Tolerogenic antigen-presenting cells
10/09/2003WO2003083083A2 Methods of using flt3-ligand in immunization protocols
10/09/2003WO2003083050A2 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog
10/09/2003WO2003083039A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/09/2003WO2003082924A1 Immunotherapeutic and immunoprophylactic reagents
10/09/2003WO2003082919A2 Ox40r binding agents
10/09/2003WO2003082874A2 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments
10/09/2003WO2003082873A1 New-4-(pyrrolopyrimidin-6-yl)benzenesulphonamide derivatives
10/09/2003WO2003082872A1 Novel pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
10/09/2003WO2003082869A1 Azaindoles as inhibitors of c-jun n-terminal kinases
10/09/2003WO2003082868A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
10/09/2003WO2003082867A1 Azaindolylpiperidine derivatives as antihistaminic and antiallergic agents
10/09/2003WO2003082863A1 N-(morpholin-2yl) methyl acetamide derivatives as ccr-3 antagonists useful in the treatment of inflammatory diseases
10/09/2003WO2003082862A1 Anti-inflammatory morpholin-acetamide derivatives
10/09/2003WO2003082859A1 Indolylmaleimide derivatives
10/09/2003WO2003082855A1 Anti-inflammatory agent
10/09/2003WO2003082841A1 5-substituted 1,1-dioxo-`1,2,5!thiazolidine-3-one derivatives as ptpase 1b inhibitors
10/09/2003WO2003082839A1 (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors
10/09/2003WO2003082837A1 Hydroxymorpholinone derivative and medicinal use thereof
10/09/2003WO2003082829A1 New aryl imidazoles and related compounds as c5a receptor modulators
10/09/2003WO2003082827A1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents
10/09/2003WO2003082813A2 Improvements in pharmaceutical compositions
10/09/2003WO2003082808A1 Benzamide derivatives
10/09/2003WO2003082787A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003WO2003082777A2 Novel glucocorticoid receptor ligands
10/09/2003WO2003082349A1 Treatment methods for eotaxin mediated inflammatory conditions
10/09/2003WO2003082322A1 A method of modulating cellular activity
10/09/2003WO2003082312A1 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
10/09/2003WO2003082308A1 Drugs including anticancer agents and immunopotentiators and health foods and drinks
10/09/2003WO2003082293A1 Benzenesulphonate salt of a morpholine urea derivative for use as a ccr-3 antagonist in the treatment of inflammatory conditions
10/09/2003WO2003082291A1 N-{´ (2s) -4- (3, 4-difluorobenzyl) morpholin-2yl!methyl} -2-{3-' (methylsulphonyl) amino! phenyl}acetamide as ccr3 antagonist for the treatment of inflammatory conditions
10/09/2003WO2003082290A1 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors
10/09/2003WO2003082285A1 Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
10/09/2003WO2003082280A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003WO2003082277A1 Thiazol-2-yl-imine compounds as pde-7 inhibitors
10/09/2003WO2003082271A2 Indole derivatives having anti-angiogenetic activity
10/09/2003WO2003082269A1 Use of statins and other immunomodulatory agents in the treatment of autoimmune disease
10/09/2003WO2003082197A2 Immunosuppressant compounds, methods and uses related thereto
10/09/2003WO2003082189A2 Method for producing pseudo islets
10/09/2003WO2003040686A3 Dosing and administration of therapeutic micro-organs in living subjects and devices and methods for same
10/09/2003WO2003022994A3 Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto
10/09/2003WO2003000878A3 Use of fkbp chaperones as expression tool
10/09/2003WO2002092011A3 Methods of treating antibody-mediated pathologies using agents which inhibit cd21
10/09/2003WO2002092004A3 Use of hmg fragment as anti-inflammatory agents
10/09/2003WO2002083627A3 Ligands des integrins avss6
10/09/2003WO2002078682A3 Estrogen replacement therapy
10/09/2003WO2002077017A3 Medical uses of intercellular communication facilitating compounds
10/09/2003WO2002071062A3 Diagnosis and treatment of inflammation and hyperactive immune conditions
10/09/2003WO2002069905A3 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders
1 ... 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 ... 1172